We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

35 hedge funds and large institutions have $35.3M invested in BioAmber Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,314% more call options, than puts

Call options by funds: $379K | Put options by funds: $7K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

9% more funds holding

Funds holding: 3235 (+3)

51% less capital invested

Capital invested by funds: $72.6M → $35.3M (-$37.3M)

Holders
35
Holders Change
+3
Holders Change %
+9.38%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
11
Reduced
8
Closed
4
Calls
$379K
Puts
$7K
Net Calls
+$372K
Net Calls Change
-$373K

BIOA Hedge Fund Activity: Q1 2017 in Review

35 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q1 2017, worth a combined $35.3M — down 51% from $72.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BIOA positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 8 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $5.55M. The largest seller was Waddell & Reed Financial, cutting an estimated $3.35M.

  • 35 institutional investors held BioAmber Inc. (BIOA) as of Q1 2017, up from 32 in Q4 2016.
  • Funds reported $35.3M of BioAmber Inc. stock for Q1 2017, down 51% quarter-over-quarter.
  • 9 funds opened new BioAmber Inc. positions in Q1 2017 and 4 closed out, a net change of +5 holders.
  • The largest BioAmber Inc. buyer in Q1 2017 was Sabby Management, an estimated $5.55M added.
  • The largest BioAmber Inc. seller in Q1 2017 was Waddell & Reed Financial, an estimated $3.35M sold.

Based on aggregated 13F filings for Q1 2017.